CIK 0000949858
- Non-accelerated filer
- Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954343413
- Phone
- +1 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-12 | Cormack Scott Daniel Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2019-05-14 | Cormack Scott Daniel Director | Grant or award · Stock Option (right to buy) | +7,000 | 7,000 | ||
| 2018-09-20 | Cormack Scott Daniel Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-10-10 | Cormack Scott Daniel President and CEO | Exercise or conversion · Restricted Stock Unit (RSU) | −3,125 | 3,125 | ||
| 2017-10-10 | Cormack Scott Daniel President and CEO | Exercise or conversion · Restricted Stock Unit (RSU) | −4,687 | 9,375 | ||
| 2017-09-08 | Cormack Scott Daniel Director | Shares withheld for taxes | −1,491 | $3.09 | $5K | 14,810 |
| 2017-08-01 | Cormack Scott Daniel Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Exercise or conversion | +3,125 | 16,302 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Exercise or conversion | +1,590 | 9,685 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Exercise or conversion · Restricted Stock Unit (RSU) | −568 | 0 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Exercise or conversion · Restricted Stock Unit (RSU) | −1,705 | 0 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Exercise or conversion · Restricted Stock Unit (RSU) | −852 | 0 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Exercise or conversion · Restricted Stock Unit (RSU) | −284 | 0 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Exercise or conversion · Restricted Stock Unit (RSU) | −852 | 0 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Exercise or conversion · Restricted Stock Unit (RSU) | −454 | 0 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2017-06-12 | Cormack Scott Daniel President and CEO | Exercise or conversion | +9,375 | 149,425 | ||
| 2017-06-12 | Cormack Scott Daniel President and CEO | Shares withheld for taxes | −4,472 | $0.36 | $2K | 144,953 |
| 2017-06-12 | Cormack Scott Daniel President and CEO | Exercise or conversion | +5,000 | 89,055 | ||
| 2017-06-12 | Cormack Scott Daniel President and CEO | Exercise or conversion · Restricted Stock Unit (RSU) | −9,375 | 9,375 |
Page 1 of 8 · 159 trades